Spark Therapeutics

Spark Therapeutics is a biotechnology company focused on developing gene therapies to treat genetic diseases. It aims to correct or replace faulty genes responsible for various conditions, including inherited blindness and hemophilia. By using innovative approaches, Spark seeks to provide long-lasting treatments that address the root causes of these diseases rather than just alleviating symptoms. Their work represents a significant advancement in medicine, offering hope for patients with serious genetic disorders by potentially restoring normal function to affected genes and improving quality of life.